Table 32:
Estimated Annual Per-Patient Costs (All Direct Medical Costs) of Continuous Glucose Monitoring in Ontario
| Intervention | Technology | Year 1, $ | Year 2, $ | Year 3, $ | Year 4, $ | Year 5, $ |
|---|---|---|---|---|---|---|
| Comparators | ||||||
| SMBG + multiple daily injections | — | 3,677 | 4,039 | 4,277 | 4,431 | 4,515 |
| SMBG + insulin pump | Animas Vibe | 6,817 | 7,175 | 7,365 | 7,450 | 7,458 |
| Interventions | ||||||
| CGM + multiple daily injections | Dexcom G4/G5 | 9,342a | 9,693a | 9,810a | 9,830a | 9,775a |
| CGM + insulin pump | Integrated | 11,673b | 12,075b | 12,126b | 12,090b | 11,980b |
| SAP with LGS | MiniMed Veo | 9,211 | 9,531 | 9,673 | 9,701 | 9,649 |
| SAP or SAP with LGS | 10% SAP; 90% SAP with LGS | 9,457 | 9,785 | 9,918 | 9,940 | 9,882 |
| Average for CGM devices | 40% CGM + multiple daily injections; 60% CGM + SAP | 9,411 | 9,748 | 9,875 | 9,896 | 9,839 |
Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend [feature]; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose.
a
Average cost of Dexcom G4 Platinum and Dexcom G5 Mobile.
b
Average cost of Dexcom G4 Platinum + Animas Vibe and Dexcom G5 Mobile + Animas Vibe.